Immune monitoring of kidney transplant recipients: Can markers predictive of over-immunosuppression be identified?;Surveillance biologique des patients transplantés rénaux : vers une prévision des complications associées à l'immunosuppression ?

Annales Pharmaceutiques Francaises

Volumn 66, Issue 2, 2008, Pages 115-121

  Saas, P ^a,b,c,d   Courivaud, C ^a,d,e   Bamoulid, J ^a,d,e   Garnache Ottou, F ^a,b,c,d   Seilles, E ^a,b,c,d   Ducloux, D ^a,d,e  

^a INSERM   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d IFR 133   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Atherosclerosis; CD4 T cell cytopenia; Immunosuppressive drugs; Innate immunity; Regulatory T cells; Transplantation

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; LYMPHOCYTE ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TOLL LIKE RECEPTOR 4;

ARTICLE; BLOOD TOXICITY; CD4+ T LYMPHOCYTE; CYTOPENIA; DIABETES MELLITUS; DIARRHEA; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DYSLIPIDEMIA; ENDOCRINE DISEASE; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HIGH RISK PATIENT; HIRSUTISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; INNATE IMMUNITY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TOXICITY; METABOLIC DISORDER; MUTATIONAL ANALYSIS; NEPHROTOXICITY; NEUROTOXICITY; OBESITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PROMOTER REGION; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; SOLID TUMOR; THROMBOCYTOPENIA; TREATMENT PLANNING; DRUG MONITORING; IMMUNOLOGY; REVIEW;

DRUG MONITORING; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION;

EID: 50649119967     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2008.03.004     Document Type: Article

References (47)

1. Sayegh M.H., and Carpenter C.B. Transplantation 50 years later--progress, challenges, and promises. N Engl J Med 351 (2004) 2761-2766
2. Meier-Kriesche H.U., Schold J.D., and Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?. Am J Transplant 4 (2004) 1289-1295
3. Ducloux D., Carron P.L., Rebibou J.M., Aubin F., Fournier V., Bresson-Vautrin C., et al. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 65 (1998) 1270-1272
4. Ducloux D., Carron P.L., Motte G., Rebibou J.M., Bresson-Vautrin C., Tiberghien P., et al. Lymphocyte subsets and assessment of cancer risk in renal transplant recipients. Transpl Int 15 (2002) 393-396
5. Denton M.D., Magee C.C., and Sayegh M.H. Immunosuppressive strategies in transplantation. Lancet 353 (1999) 1083-1091
6. Ducloux D., Kazory A., and Chalopin J.M. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 79 (2005) 438-443
7. Ojo A.O. Cardiovascular complications after renal transplantation and their prevention. Transplantation 82 (2006) 603-611
8. Ducloux D., Challier B., Saas P., Tiberghien P., and Chalopin J.M. CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol 14 (2003) 767-772
9. Ducloux D., Bresson-Vautrin C., Kribs M., Abdelfatah A., and Chalopin J.M. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 62 (2002) 1417-1422
10. Ducloux D., Deschamps M., Yannaraki M., Ferrand C., Bamoulid J., Saas P., et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 67 (2005) 2454-2461
11. Courivaud C., Ferrand C., Deschamps M., Tiberghien P., Chalopin J.M., Duperrier A., et al. No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation. Transplantation 81 (2006) 1212-1215
12. Bamoulid J., Courivaud C., Deschamps M., Mercier P., Ferrand C., Penfornis A., et al. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J Am Soc Nephrol 17 (2006) 2333-2340
13. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N Engl J Med 351 (2004) 2715-2729
14. Taylor A.L., Watson C.J., and Bradley J.A. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 56 (2005) 23-46
15. Muller T.F., Grebe S.O., Neumann M.C., Heymanns J., Radsak K., Sprenger H., et al. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 64 (1997) 1432-1437
16. Louis S., Audrain M., Cantarovich D., Schaffrath B., Hofmann K., Janssen U., et al. Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids. Transplantation 83 (2007) 712-721
17. Ducloux D., Carron P.L., Racadot E., Rebibou J.M., Bresson-Vautrin C., Saint-Hillier Y., et al. CD4 lymphocytopenia in long-term renal transplant recipients. Transplant Proc 30 (1998) 2859-2860
18. Ducloux D., Carron P., Racadot E., Rebibou J.M., Bresson-Vautrin C., Hillier Y.S., et al. T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies. Transpl Int 12 (1999) 250-253
19. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
20. Weinberg K., Blazar B.R., Wagner J.E., Agura E., Hill B.J., Smogorzewska M., et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97 (2001) 1458-1466
21. Hazenberg M.D., Otto S.A., de Pauw E.S., Roelofs H., Fibbe W.E., Hamann D., et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 99 (2002) 3449-3453
22. Clave E., Rocha V., Talvensaari K., Busson M., Douay C., Appert M.L., et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood. 105 (2005) 2608-2613
23. Zeiser R., Nguyen V.H., Beilhack A., Buess M., Schulz S., Baker J., et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108 (2006) 390-399
24. Gao W., Lu Y., El Essawy B., Oukka M., Kuchroo V.K., and Strom T.B. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 7 (2007) 1722-1732
25. Jiang H., and Chess L. Regulation of immune responses by T cells. N Engl J Med 16 354 (2006) 1166-1176
26. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
27. Izcue A., Coombes J.L., and Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212 (2006) 256-271
28. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
29. Mallat Z., and Tedgui A. Immunomodulation to combat atherosclerosis: the potential role of immune regulatory cells. Expert Opin Biol Ther 4 (2004) 1387-1393
30. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 (2006) 508-519
31. Ducloux D., Bourrinet E., Motte G., and Chalopin J.M. Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients. Kidney Int 64 (2003) 1065-1070
32. Kawai T., and Akira S. TLR signaling. Cell Death Differ 13 (2006) 816-825
33. Philpott D.J., and Girardin S.E. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 41 (2004) 1099-1108
34. Binder C.J., Chang M.K., Shaw P.X., Miller Y.I., Hartvigsen K., Dewan A., et al. Innate and acquired immunity in atherogenesis. Nat Med 8 (2002) 1218-1226
35. Miller Y.I., Viriyakosol S., Worrall D.S., Boullier A., Butler S., and Witztum J.L. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 25 (2005) 1213-1219
36. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 185-192
37. Fekete A., Viklicky O., Hubacek J.A., Rusai K., Erdei G., Treszl A., et al. Association between heat shock protein 70s and toll-like receptor polymorphisms with long-term renal allograft survival. Transpl Int 19 (2006) 190-196
38. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
39. Anonymous. Freely Associating. Nat Genet 22 (1999) 1-3
40. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
41. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem J 265 (1990) 621-636
42. Weimer R., Mytilineos J., Feustel A., Preiss A., Daniel V., Grimm H., et al. Mycophenolate mofetilbased immunosuppression and cytokine genotypes: effects on monokines secretion and antigen presentation in long-term renal transplant recipients. Transplantation 75 (2005) 2090-2099
43. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
44. Reuss E., Fimmers R., Kruger A., Becker C., Rittner C., and Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study. Genes Immun 3 (2002) 407-413
45. Lau A.H., Turnquist H., Tokita D., Zeevi A., Mazariegos G., and Thomson A. Tolerance assays: the physician's guide to safe weaning of immunosuppression?. Transplantation Rev 20 (2006) 208-221
46. Salama A.D., Womer K.L., and Sayegh M.H. Clinical transplantation tolerance: many rivers to cross. J Immunol 178 (2007) 5419-5423
47. Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21 (2007) 1387-1394